Baxter Nicholas W 4
4 · Lexaria Bioscience Corp. · Filed Jun 1, 2018
Insider Transaction Report
Form 4
Baxter Nicholas W
Director
Transactions
- Purchase
Options
2018-05-31+50,000→ 160,000 totalExercise: $1.53From: 2023-05-31Exp: 2023-05-31→ Lexaria Common Shares (50,000 underlying)
Holdings
- 110,000
Options
Exercise: $0.10From: 2019-12-23Exp: 2019-12-23→ Lexaria Common Shares (110,000 underlying)